Epigenomics AG / Key word(s): PersonnelEpigenomics AG: Executive Board member Jens Ravens leaves the Company on April 30, 2024 30-Oct-2023 / 15:49 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News – a service of EQS Group AG.The issuer is solely responsible for the […]
Category: Insider Information
30. October 2023
Epigenomics AG: Executive Board member Jens Ravens leaves the Company on April 30, 2024
Read more
10. October 2023
Epigenomics AG: Closing of Agreement on the Acquisition of Almost All Assets and Adjustment of Guidance for 2023
Epigenomics AG / Key word(s): Contract/DisposalEpigenomics AG: Closing of Agreement on the Acquisition of Almost All Assets and Adjustment of Guidance for 2023 10-Oct-2023 / 20:56 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News – a service of EQS Group AG.The issuer is […]
11. September 2023
Epigenomics AG: Approval by the Extraordinary General Meeting of the acquisition of almost all assets and corresponding change of the statutory purpose of the Company
Epigenomics AG / Key word(s): AGM/EGMEpigenomics AG: Approval by the Extraordinary General Meeting of the acquisition of almost all assets and corresponding change of the statutory purpose of the Company 11-Sep-2023 / 15:54 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News – a […]
02. August 2023
Epigenomics AG: Capital reduction planned at a ratio of 5 : 1
Epigenomics AG / Key word(s): Corporate Action/MiscellaneousEpigenomics AG: Capital reduction planned at a ratio of 5 : 1 02-Aug-2023 / 10:36 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News – a service of EQS Group AG.The issuer is solely responsible for the content […]
24. July 2023
Epigenomics AG: Agreement on the Acquisition of Almost All Assets
Epigenomics AG / Key word(s): Strategic Company Decision/ContractEpigenomics AG: Agreement on the Acquisition of Almost All Assets 24-Jul-2023 / 18:29 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News – a service of EQS Group AG.The issuer is solely responsible for the content of […]
12. June 2023
Epigenomics AG: Negotiations on the Acquisitions of Almost All Assets
Epigenomics AG / Key word(s): MiscellaneousEpigenomics AG: Negotiations on the Acquisitions of Almost All Assets 12-Jun-2023 / 10:21 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News – a service of EQS Group AG.The issuer is solely responsible for the content of this announcement. […]